1.5 Clinical Enzymology, Cardiac & Liver Markers

Clinical Enzymology, Cardiac, and Liver Markers

Principles of Clinical Enzymology

Enzymes are specialized biological proteins that act as catalysts, vastly accelerating the rate of specific biochemical reactions without being consumed or permanently altered in the process. In clinical chemistry, it is technically difficult and expensive to measure the actual mass or protein concentration of an enzyme. Instead, the laboratory measures the enzyme's activity—how fast it converts substrate into product.

Enzyme Kinetics

To accurately measure the amount of enzyme present in a patient's serum based on its activity, the laboratory assay must be carefully designed to operate under specific kinetic conditions:

• First-Order Kinetics: The reaction rate is directly proportional to the substrate concentration. If you double the substrate, the reaction doubles. The enzyme is in excess, and the substrate is the limiting factor. This is not used for measuring enzymes.
• Zero-Order Kinetics: The substrate concentration is in vast excess, fully saturating all available enzyme active sites. The reaction rate reaches its maximum velocity (Vmax) and becomes independent of further increases in substrate. Under zero-order kinetics, the only variable determining the reaction rate is the amount of the patient's enzyme present. All clinical assays for measuring enzyme activity must follow zero-order kinetics.

Enzyme activity is profoundly affected by environmental factors. Assays must strictly control pH (using buffers), temperature (usually set precisely to 37°C), and the presence of necessary cofactors (e.g., magnesium, zinc) or coenzymes (like NAD/NADH, whose conversion is frequently monitored spectrophotometrically at 340 nm).

Cardiac Biomarkers

When cardiac muscle undergoes ischemia and necrosis during an Acute Myocardial Infarction (AMI), structural proteins and intracellular enzymes leak through the damaged cell membranes into the systemic circulation. The timeline of their appearance in the blood is critical for diagnosis.

Troponin (cTnT and cTnI)

Troponins are structural proteins involved in the regulation of cardiac muscle contraction. The cardiac-specific isoforms, cTnI and cTnT, are currently the absolute gold standard and preferred biomarkers for diagnosing AMI.

• Kinetics: Troponin levels begin to rise in the serum 3-4 hours after the onset of myocardial injury. They peak between 12-24 hours and, importantly, remain elevated for a prolonged period of 7-14 days.
• High-Sensitivity Troponin (hs-cTn): Modern high-sensitivity assays can detect minute quantities of troponin, allowing for the rapid "rule-in" or "rule-out" of a heart attack within 1 to 2 hours of presentation to the emergency department.

Creatine Kinase (CK) and CK-MB

Creatine Kinase is an enzyme involved in energy storage in muscle tissues. It exists as three isoenzymes based on dimer subunit composition (M for muscle, B for brain): CK-MM (skeletal and cardiac muscle), CK-MB (primarily cardiac muscle), and CK-BB (brain tissue).

• Historically, measuring the CK-MB mass or calculating the CK-MB relative index (CK-MB mass / Total CK activity) was the standard for AMI diagnosis. However, Troponin has largely replaced it due to superior specificity and sensitivity. CK-MB remains useful in one specific scenario: diagnosing a re-infarction shortly after an initial heart attack, because CK-MB returns to baseline within 2-3 days, whereas Troponin remains elevated for weeks.

Myoglobin

Myoglobin is a small, oxygen-binding heme protein found in all skeletal and cardiac muscle. Its primary advantage is speed; it is the very first biomarker to rise after muscle injury (within 1-3 hours). However, it is entirely non-specific to the heart. Any muscle trauma, extreme exercise, or rhabdomyolysis will cause massive elevations. A negative myoglobin can rule out an AMI early, but a positive result is clinically ambiguous.

B-Type Natriuretic Peptide (BNP)

BNP is not a marker of necrosis. It is a neurohormone secreted by the ventricles of the heart in response to excessive stretching and volume overload. It promotes diuresis and vasodilation to reduce cardiac workload. BNP (and its inactive fragment NT-proBNP) is the primary biomarker for diagnosing and staging Congestive Heart Failure (CHF).

Hepatic Enzyme Panels

Liver enzymes are broadly categorized into two distinct groups based on the anatomical location of the enzyme and the type of pathology they reflect.

Markers of Hepatocellular Necrosis (Transaminases)

These enzymes reside inside the hepatocytes. They leak into the blood when liver cells are damaged, inflamed, or dying (e.g., viral hepatitis, toxic liver injury, acetaminophen overdose).

• Alanine Aminotransferase (ALT): Found predominantly in the liver. It is considered highly specific for hepatocellular injury.
• Aspartate Aminotransferase (AST): Found in the liver, but also widely distributed in cardiac muscle, skeletal muscle, and red blood cells. It is less specific to the liver than ALT.
• The De Ritis Ratio (AST/ALT): In most forms of acute viral hepatitis, ALT is higher than AST (ratio < 1.0). However, in alcoholic hepatitis or cirrhosis, AST is classically much higher than ALT (ratio > 2.0).

Markers of Biliary Obstruction (Cholestasis)

These enzymes are membrane-bound, primarily located on the canalicular surface of the bile ducts. Their synthesis is massively induced when the flow of bile is obstructed (cholestasis, gallstones, biliary strictures).

• Alkaline Phosphatase (ALP): Found heavily in the liver and biliary tract, but also in bone (osteoblasts), the placenta, and the intestines. Elevated ALP can indicate biliary obstruction or high bone turnover (e.g., Paget's disease, growing children).
• Gamma-Glutamyl Transferase (GGT): Found primarily in the hepatobiliary tract. It is highly sensitive for any liver disease and uniquely sensitive to occult alcohol consumption.
• Diagnostic Utility: GGT is clinically used to determine the tissue origin of an elevated ALP. If a patient has a high ALP and a high GGT, the source is definitely hepatobiliary. If a patient has a high ALP but a perfectly normal GGT, the source is definitively bone.

Pancreatic Enzymes

• Amylase: An enzyme that breaks down complex starches. It is secreted by the acinar cells of the pancreas and the salivary glands. In acute pancreatitis, serum amylase rises rapidly (within 5-8 hours) but is quickly cleared by the kidneys, returning to normal in 2-3 days.
• Lipase: An enzyme that hydrolyzes dietary triglycerides. It is secreted almost exclusively by the pancreas. Lipase is the preferred, highly specific biomarker for diagnosing acute pancreatitis. It rises parallel to amylase but remains elevated much longer (up to 7-14 days), providing a wider diagnostic window.